Albert Bourla
Albert Bourla (businessman, veterinarian) | |
---|---|
Born | October 21, 1961 Thessaloniki, Greece |
Nationality | Greek |
Alma mater | Aristotle University of Thessaloniki |
Religion | Jewish |
Member of | Atlantic Council/Distinguished Leadership Awards, Business Roundtable |
Albert Bourla is a Greek-Israeli veterinarian and the chairman and chief executive officer of Pfizer, the American Big Pharma company with the COVID-19 vaccine favored by the deep state.
Career
Born in the northern Greece city of Thessaloniki on October 21, 1961, he is part of the long history of the Sephardic Jews.[1]
After graduating from high school Bourla went on to study at the Aristotle University of Thessaloniki. He graduated with a PhD in veterinary medicine and worked as a veterinarian for a time. He joined Pfizer in 1993, first serving as a doctor of veterinary medicine and technical director for the company’s animal health division in Greece.[1]
At the age of 34 he left Thessaloniki with his wife to join Pfizer Europe and work in several positions, coming to live in four different countries. He served as Pfizer’s Animal Health division president for Europe, Africa and Middle East during 2005–2009, followed by the Europe, Africa, and Asia Pacific division during 2009–2010. During this tenure, Pfizer bought the company Wyeth (including Fort Dodge Animal Health)[2] which had introduced a DNA-based vaccine for horses against the West Nile Virus.[3] He also worked as Group President of Pfizer’s Global Vaccines, Oncology and Consumer Healthcare business.[1]
After working for Pfizer for 25 years, he was promoted to Chief Operating Officer (COO) on January 1st 2018, and on January 1st 2019 he became Pfizer’s Chief Executive Officer.
In addition to the boards of Pfizer and the Pfizer Foundation, he serves or has served on the boards of the Biotechnology Innovation Organization, Catalyst, the Partnership for New York City, and the Pharmaceutical Research and Manufacturers of America. Bourla is also a member of The Business Council and the Business Roundtable. He engages often with business leaders such as Bill Gates.[4]
“The dynamics in the COVID more and more indicate a potential that we will have a clearly repeated business… Now we still don’t have data about the immunity of our vaccine because it is early. But we do see that the people that have the disease, more and more publications indicate that after several months, the immune response goes down. So there is a need to boost.””
Albert Bourla [5]
Events Participated in
Event | Start | End | Location(s) | Description |
---|---|---|---|---|
Bilderberg/2022 | 2 June 2022 | 5 June 2022 | US Washington DC Mandarin Oriental Hotel | The 68th Bilderberg Meeting, held in Washington DC, after an unprecedented two year hiatus during which a lot of the Bilderberg regulars were busy managing COVID-19 |
Bilderberg/2023 | 18 May 2023 | 21 May 2023 | Portugal Lisbon Pestana Palace Hotel | The 69th Bilderberg Meeting, held in Lisbon, with 128 guests on the official list. The earliest in the year since 2009. |
Bilderberg/2024 | 30 May 2024 | 2 June 2024 | Spain Madrid | The 70th Bilderberg Meeting |
WEF/Annual Meeting/2022 | 22 May 2022 | 26 May 2022 | World Economic Forum Switzerland | 1912 guests in Davos |
WEF/Annual Meeting/2023 | 16 January 2023 | 20 January 2023 | World Economic Forum Switzerland | The theme of the meeting was "Cooperation in a Fragmented World" |
References
- ↑ a b c https://esefarad.com/?p=100606
- ↑ https://www.reuters.com/article/us-wyeth-pfizer-idUSTRE50M1AQ20090126M
- ↑ https://equusmagazine.com/news/horses-contribute-covid-vaccine
- ↑ https://www.bloomberg.com/news/articles/2019-03-07/nyc-business-leaders-call-for-renewed-mayoral-school-control
- ↑ https://s21.q4cdn.com/317678438/files/doc_financials/2020/q4/PFE-USQ_Transcript_2021-02-02.pdf